TGF-α and amphiregulin levels in non-small cell lung cancer (NSCLC) patients (pts) treated with erlotinib/placebo in the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) BR.21 ...
The new study can help understanding diseases stemming from the abnormal functions of the human receptor tyrosine kinases, RTKs. Much of the cell-to-cell communication is facilitated in humans by 58 ...
Here, we report robust response to RTK inhibition of a patient with NB harboring a rare germline variant in the ALKAL2 gene with a chromosomal 2p gain and ALK and TRK activity. On the basis of this ...
PI3K signaling pathways. Upon activation by RTK, GPCR, Integrin, and Ras, p110 loses inhibition by p85 and converts PIP2 to PIP3. PIP3 recruits AKT to the cell membrane, where AKT is activated through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results